Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae

OBJECTIVES: Besifloxacin is a novel fluoroquinolone that was recently approved for topical treatment of bacterial conjunctivitis. The compound was shown to be active in vitro against a broad spectrum of bacteria, including isolates resistant to other antibacterials. Here, the bactericidal activity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, Wolfgang, Pillar, Chris M., Hesje, Christine K., Sanfilippo, Christine M., Morris, Timothy W.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882870/
https://www.ncbi.nlm.nih.gov/pubmed/20435780
http://dx.doi.org/10.1093/jac/dkq127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882870/
https://www.ncbi.nlm.nih.gov/pubmed/20435780
http://dx.doi.org/10.1093/jac/dkq127

Ejemplares similares